Cargando…
Individualized therapy of HHT driven by network analysis of metabolomic profiles
BACKGROUND: Hereditary Hemorrhagic Telangiectasia (HHT) is an autosomal dominant disease with a varying range of phenotypes involving abnormal vasculature primarily manifested as arteriovenous malformations in various organs, including the nose, brain, liver, and lungs. The varied presentation and i...
Autores principales: | Jamshidi, Neema, Miller, Franklin J, Mandel, Jess, Evans, Timothy, Kuo, Michael D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339509/ https://www.ncbi.nlm.nih.gov/pubmed/22185482 http://dx.doi.org/10.1186/1752-0509-5-200 |
Ejemplares similares
-
Hereditary Hemorrhagic Telangiectasia (HHT) and Survival: The Importance of Systematic Screening and Treatment in HHT Centers of Excellence
por: de Gussem, Els M., et al.
Publicado: (2020) -
Genotype–Phenotype Correlations in Children with HHT
por: Kilian, Alexandra, et al.
Publicado: (2020) -
Mononuclear cells and vascular repair in HHT
por: Dingenouts, Calinda K. E., et al.
Publicado: (2015) -
HHT diagnosis by Mid-infrared spectroscopy and artificial neural network analysis
por: Lux, Andreas, et al.
Publicado: (2013) -
Sclerotherapy on Demand with Polidocanol to Treat HHT Nosebleeds
por: Marcos, Sol, et al.
Publicado: (2021)